<--- Back to Details
First PageDocument Content
Cilag / Janssen Pharmaceutica / Grünenthal GmbH / Dai-ichi / Pharmaceutical industry / Johnson & Johnson / Daiichi Sankyo / Janssen-Cilag
Date: 2014-06-28 10:51:03
Cilag
Janssen Pharmaceutica
Grünenthal GmbH
Dai-ichi
Pharmaceutical industry
Johnson & Johnson
Daiichi Sankyo
Janssen-Cilag

Press Release Daiichi Sankyo Europe GmbH Zielstattstrasse[removed]Munich · Germany Phone +[removed]

Add to Reading List

Source URL: www.daiichi-sankyo.eu

Download Document from Source Website

File Size: 41,16 KB

Share Document on Facebook

Similar Documents

April 1, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

DocID: 1rsbj - View Document

benicar with hct what kind of med is benicar, benicar hc. benicar hct and insomnia. benicar hct tablets substitute benicar for micardis benicar contra drug side effect benicar benicar hct by daiichi-sankyo, benicar and b

benicar with hct what kind of med is benicar, benicar hc. benicar hct and insomnia. benicar hct tablets substitute benicar for micardis benicar contra drug side effect benicar benicar hct by daiichi-sankyo, benicar and b

DocID: 1r6JO - View Document

May 6, IMS Health, Quintiles Agree to Merge IMS Health Holdings, Inc., the pharmaceutical market information and technology provider, and Quintiles Transnational Holdings Inc., a contract rese

May 6, IMS Health, Quintiles Agree to Merge IMS Health Holdings, Inc., the pharmaceutical market information and technology provider, and Quintiles Transnational Holdings Inc., a contract rese

DocID: 1p3Zj - View Document

Press Release Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC) Tokyo, Japan and Parsippany, NJ– (May 31, 2016) – Daiichi Sankyo Company, Limited (hereafter, Daiich

Press Release Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC) Tokyo, Japan and Parsippany, NJ– (May 31, 2016) – Daiichi Sankyo Company, Limited (hereafter, Daiich

DocID: 1o6nw - View Document

For Immediate Release ASAHIKAWA MEDICAL UNIVERSITY DAIICHI SANKYO COMPANY, LIMITED MITSUBISHI UFJ CAPITAL CO., LTD.  Open innovation research on new stem cells by Asahikawa Medical University,

For Immediate Release ASAHIKAWA MEDICAL UNIVERSITY DAIICHI SANKYO COMPANY, LIMITED MITSUBISHI UFJ CAPITAL CO., LTD. Open innovation research on new stem cells by Asahikawa Medical University,

DocID: 1o1QP - View Document